USAGE OF NUKLEX IN THERAPY OF PATIENTS WITH HEPATITIS C

Authors

  • B.M. Dyky Тернопільський державний медуніверситет ім. І.Я. Горбачевського
  • O.Ye. Kondryn
  • O.Ya. Pryshliak
  • Z.Yu. Tkaschuk

DOI:

https://doi.org/10.11603/1681-2727.2012.2.476

Abstract

Usage of Nuklex for treatment of hepatitis C is accompanied by a rapid disappearance of the main clinical symptoms, improvement of health in the patients, supports normalization of cytolytic liver function in patients with minimal or moderate activity hepatitis. Based on the obtained  data, it can be considered the isolate usage of Nuklex as the only antiviral drug for hepatitis C patients with low initial viral load HCV (<800,000 IU/ml) in a daily dose of 1.5 g. It is rather prospective to continue to study the efficiency of Nuklex in patients with hepatitis C with an initial high viral load HCV (>800,000 IU/ml) in complex therapy with other antiviral drugs

Author Biography

B.M. Dyky, Тернопільський державний медуніверситет ім. І.Я. Горбачевського

Відповідальний секретар журналу "Інфекційні хвороби", професор.

Downloads

Published

2013-06-21

How to Cite

Dyky, B., Kondryn, O., Pryshliak, O., & Tkaschuk, Z. (2013). USAGE OF NUKLEX IN THERAPY OF PATIENTS WITH HEPATITIS C. Infectious Diseases – Infektsiyni Khvoroby, (2). https://doi.org/10.11603/1681-2727.2012.2.476

Issue

No. 2 (2012)

Section

Статті

License

Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration

Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes

 Лицензия Creative Commons

This journal is available through Creative Commons (CC) License  BY-NC "Attribution-NonCommercial" 4.0